🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 917273104
- Market Cap
- Micro Cap · $12 Million
Business: Urologix, Inc. develops, manufactures and markets minimally invasive urological treatment products. Urologix has developed and offers non-surgical, catheter-based treatments that use proprietary microwave technology for the treatment of benign prostatic hyperplasia (BPH), a condition that affects more than 23 million men worldwide. Urologix is a leader in less invasive technology for the BPH treatment, with more than 225,000 patients treated. The company is focused on product development and expansion of its fast-growing mobile BPH treatment services.
Company Contact
- CEO
- Stryker Warren Jr.
- CFO
- ian J. Smrdel
- Headquarters
- 14405 21st Avenue North, Minneapolis, MN 55447
- Phone
- 763-475-1400 · Toll-Free 800-475-1403
- Fax
- 763-475-1443
- Investor Relations
- Melanie Hill · 763-475-7682 · mhill@urologix.com